ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 22 filers reported holding ENVVENO MEDICAL CORPORATION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $853,916 | +331.5% | 158,426 | +146.6% | 0.00% | – |
| Q2 2023 | $197,884 | -3.1% | 64,248 | +48.7% | 0.00% | – |
| Q1 2023 | $204,298 | -36.6% | 43,192 | -31.6% | 0.00% | – |
| Q4 2022 | $322,117 | -78.4% | 63,160 | -73.4% | 0.00% | – |
| Q3 2022 | $1,491,000 | +37.8% | 237,400 | -17.1% | 0.00% | – |
| Q2 2022 | $1,082,000 | -32.5% | 286,369 | +13.8% | 0.00% | – |
| Q1 2022 | $1,603,000 | -47.6% | 251,600 | -45.8% | 0.00% | – |
| Q4 2021 | $3,060,000 | – | 464,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $2,556,000 | 2.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $1,396,000 | 0.14% |
| Perceptive Advisors | 781,615 | $4,978,000 | 0.10% |
| Kepos Capital LP | 50,000 | $319,000 | 0.02% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 15,000 | $96,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 33,372 | $213,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 49,600 | $316,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,045 | $13,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $89,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |